Arresto BioSciences preclinical data

In a mouse model of cancer, AB0023 significantly reduced tumor volume vs. vehicle-treated controls at days 21 and 35 (p=0.001 and p=0.022, respectively). The mAb against lysyl oxidase-like 2 (LOXL2) ...